While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be ...

Days after FDA Commissioner Marty Makary appeared to malign uniQure’s AMT-130 in an interview with CNBC, the agency confirmed ...

Mental health experts break down some common myths that persist around the experience of therapy.

The research revealed serious flaws that could allow cyber attackers to access private therapy transcripts, mood logs, ...

New York's post-election Subway Therapy Wall of Post-it Notes. Credit: Benny J Johnson/REX/Shutterstock In the emotional days following the November 2016 election ...

RGX-121 was rejected in early February, with Regenxbio listing the primary reasons given by the FDA as concerns about the ability to properly define a patient population, the use of a natural history ...

Off-campus mental health resources include a 24/7 hotline, outpatient therapy and an intensive outpatient program.

Pediatric brain tumors represent a significant health challenge as they are the second most common form of childhood cancer and a leading cause of ...

Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...

Agency staff "strongly recommended" a sham surgery-controlled trial be conducted before an approval filing, a stance one analyst called a "worst case scenario" for UniQure.

Dear Eric: Our son, who is in college, began losing his hair in high school. It could be genetic, but this does not run in the family. Although he is skinny, he eats terribly. He fills up on junk food ...

At Students' Council on February 10, Farah Elgaweesh presented on concerns from the HSSA, and Ewan Hussler became the ...